A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients
Clinical trial NCT00518323 · COMPLETED
Trial details
- NCT number
- NCT00518323
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-03-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.